Cart
sales@molnova.com
Stemazole
CAS No. 317337-07-8
Stemazole( —— )
Catalog No. M34431 CAS No. 317337-07-8
Stemazole is a novel small molecule human stem/progenitor cell proliferation activator that promotes the survival of human embryonic stem cells and maintains stemness, and promotes the survival of oligodendrocyte precursor cells in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 91 | In Stock |
|
| 5MG | 98 | In Stock |
|
| 10MG | 159 | In Stock |
|
| 25MG | 334 | In Stock |
|
| 50MG | 520 | In Stock |
|
| 100MG | 840 | In Stock |
|
| 200MG | 1125 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameStemazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionStemazole is a novel small molecule human stem/progenitor cell proliferation activator that promotes the survival of human embryonic stem cells and maintains stemness, and promotes the survival of oligodendrocyte precursor cells in vitro.
-
DescriptionStemazole is a protective agent that promotes stem cell survival. Stemazole has the protective effect of human embryonic stem cells (hESCs). Stemazole enhances clonal expansion of single cells and decreases apoptosis. Stemazole for the study of stem cell survival in starvation culture .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number317337-07-8
-
Formula Weight267.33
-
Molecular FormulaC9H9N5OS2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C1OC(C2=CC=C(NC(NN)=S)C=C2)=NN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sun Y, et al. Stemazole promotes survival and preserves stemness in human embryonic stem cells. FEBS J. 2018 Feb;285(3):531-541.?
molnova catalog
related products
-
(S)-Thalidomide
(S)-Thalidomide ((S)-(-)-Thalidomide) is the S-isomer of Thalidomide with immunomodulatory, anti-inflammatory, anticancer, anti-angiogenic, and pro-apoptotic activities, used in studying leprosy erythema nodosum and myeloma.
-
CCCI-01
CCCI-01（Centrosome Clustering Chemical Inhibitor-01） is a centrosome cluster inhibitor. CCCI-01 has anticancer activity, induces apoptosis, and can be used in the study of non-cross-resistant anticancer compounds that block centrosome clustering.
-
Bacopaside II
Bacopaside II is a potential anti-angiogenic agent, it can reduce endothelial cell migration and tubulogenesis and induce apoptosis.
